Overview
Andrew Chase practices in Southampton, United Kingdom. Mr. Chase is rated as a Distinguished expert by MediFind in the treatment of Trichorhinophalangeal Syndrome Type 1 (TRPS1). His top areas of expertise are Schinzel-Giedion Syndrome, Trichorhinophalangeal Syndrome Type 1 (TRPS1), Philadelphia-Negative Chronic Myeloid Leukemia, and Chronic Myelogenous Leukemia (CML).
His clinical research consists of co-authoring 24 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Schinzel-Giedion SyndromeMr. Chase isDistinguished. Learn about Schinzel-Giedion Syndrome.
- Trichorhinophalangeal Syndrome Type 1 (TRPS1)
- Advanced
- Philadelphia-Negative Chronic Myeloid Leukemia
- Experienced
- Blood ClotsMr. Chase isExperienced. Learn about Blood Clots.
- Chronic Myelogenous Leukemia (CML)Mr. Chase isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Chronic Myelomonocytic Leukemia (CMML)
- Essential ThrombocythemiaMr. Chase isExperienced. Learn about Essential Thrombocythemia.
- Hypereosinophilic SyndromeMr. Chase isExperienced. Learn about Hypereosinophilic Syndrome.
- LeukemiaMr. Chase isExperienced. Learn about Leukemia.